S&P Futures
4,069.25 -15.00 (-0.37%) Dow Futures
33,948.00 -98.00 (-0.29%) Nasdaq Futures
12,164.75 -57.50 (-0.47%) Russell 2000 Futures
1,911.80 -7.70 (-0.40%) Crude Oil
79.26 -0.42 (-0.53%) Gold
1,946.90 +1.30 (+0.07%)
IDEXX Laboratories, Inc. (IDXX)
After hours:
Chart Events
Performance Outlook
| Previous Close | 487.00 |
| Open | 483.45 |
| Bid | 0.00 x 800 |
| Ask | 0.00 x 800 |
| Day's Range | 481.38 - 488.27 |
| 52 Week Range | 317.06 - 574.33 |
| Volume | |
| Avg. Volume | 504,881 |
| Market Cap | 41.294B |
| Beta (5Y Monthly) | 1.14 |
| PE Ratio (TTM) | 72.58 |
| EPS (TTM) | 6.71 |
| Earnings Date | Jan 31, 2023 - Feb 06, 2023 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 479.63 |
- PR Newswire
IDEXX Laboratories to Release 2022 Fourth Quarter and Full Year Financial Results
IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, has scheduled the release of its 2022 fourth quarter and full year financial results for Monday, February 6, 2023 before the market opens. The Company will conduct an analyst conference call beginning at 8:30 a.m. ET on that day.
- TheStreet.com
IDEXX Laboratories Is Barking Up the Right Tree
In the daily bar chart of IDXX, below, I see a base pattern and an upside breakout and rally. The On-Balance-Volume (OBV) line is showing strength in January after a long sideways move from May. The Moving Average Convergence Divergence (MACD) oscillator is above the zero line but shows some narrowing that needs to be monitored. The weekly OBV line has been improving since October.
- Zacks
Idexx Laboratories (IDXX) Earnings Expected to Grow: What to Know Ahead of Q4 Release
Idexx (IDXX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
